论文信息 - The REMAR (Rhein-Main-Registry) real-world study: prospective evaluation of the 21-gene breast recurrence score® assay in addition to Ki-67 for adjuvant treatment decisions in early-stage breast cancer - 字舞流文

The REMAR (Rhein-Main-Registry) real-world study: prospective evaluation of the 21-gene breast recurrence score® assay in addition to Ki-67 for adjuvant treatment decisions in early-stage breast cancer

D. Giesecke | U. Hurst | L. Anastasiadou | Marc Thill | Volker Möbus | H. Tesch | C. Jackisch | Christine Solbach | Sebastian Aulmann | Athanasios Argyriadis | Peter Baier | Sven Ackermann | E. Schulmeyer | Boris Gabriel | Dietrich Mosch | Stephanie Buchen | Eckart Krapfl | Mario Vescia